Publications

Mirabaud Brochure

Find out more about the Mirabaud Group, its activities, its values, its history and its commitments

English

French

German

Spanish

Italian

Arabic

Portuguese

Press releases

Mirabaud advises pharmaceutical trailblazer Scailyte on CHF 6 million series a funding

Zurich, 21 September 2022 – Mirabaud Advisors has acted as exclusive advisor to Swiss pharmaceutical innovator Scailyte in a CHF 6 million Series A fund raise from various investors

Read more

Views of our experts

Higher electricity costs will hurt – The current situation for Swiss Industrials

The half-year numbers of Swiss Industrials, reported in July or August, were good, mostly unaffected by the rapid price increase of raw materials. Pricing power was strong, and in an environment with solid economy data, companies were able to respond quickly to the cost pressure. Arguably, there were some exceptions: Bystronic, Daetwyler, Forbo and Schweiter, which warned before and/or missed market consensus.

Read more